Today, induced pluripotent stem cells (iPSCs) are being exploited for uses in drug discovery and development, toxicology screening, disease modelling, personalized medicine, cell-based therapeutics, and beyond. A fascinatingly diverse range of business models have been developed by market competitors to provide iPSC specific products, services, technologies, and therapies across the life science sector. [Read more…]
Setting the Standard in Adipose-Derived Stem Cell Applications

This article is part two of my interview with Matthew Feshbach, CEO and Co-Founder of Okyanos (pronounced “Oh – key – AH – nos”). Founded in 2011, Okyanos specializes in treating patients with chronic, degenerative conditions. Located in Freeport, Grand Bahama, just 55 miles from the United States, Okyanos Cell Therapy combines a blend of stem and regenerative cells derived from a patient’s own adipose (fat) tissue. [Read more…]
Nucleus Biologics Launches QuickStart Media™: A Suite of Optimized Media Formulations That Provide a Head Start on Your Therapy Optimization
SAN DIEGO, August 08, 2024 — Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media and buffers for the cell and gene therapy industry, proudly announces the launch of a novel platform to expedite the formulation and manufacture of custom media. This platform, called QuickStart Media™, is a groundbreaking addition to its comprehensive line of cell culture products and solutions and further demonstrates Nucleus Biologics’ expertise and dedication to the delivery of custom cell culture media, buffers, reagents, and services simpler and faster. [Read more…]
Regenerative Stem Cell Therapy as Treatment for Neck Pain
Neck pain is one of the most pervasive problems in the world today. At any given time, 10 percent of adults report a stiff neck, while X-rays show signs of osteoarthritis in as much as 50 percent of the population over 50. As though that wasn’t enough, 40 percent of males and almost 30 percent of females in the mid-50s and 60s exhibit problems with discs, the round cushioning devices that separate vertebrae. Needless to say, treatment for neck pain is a serious need.
While it doesn’t constitute a deadly disease, neck pain does have the power to negatively impact a person’s life every single day. It makes mobility challenging, hampers daily activities, dampens the pleasure of human touch or hugs, and generally reduces the quality of life. Up until now, medical approaches have included chiropractic care, heating and icing, over-the-counter medication use and surgery. As a rule, those solutions are either too limited or too extreme.
Now there’s a new treatment for neck pain in town: stem cells. These “master cells” have the ability to transform into bodily structures that otherwise would not rebuild, renew, and heal. This offers a very promising neck pain treatment. But what is it? And how does it work?
In this article:
Interview with Accellta’s Intellectual Property (IP) Officer, Eran Cohen
This is an follow-up to our interview with Accellta’s CEO, Dr. Itzchak Angel, who highlighted Accellta’s unique technologies for enabling large scale growth of cells in suspension. This interview features insights from Eran Cohen, Accellta’s head of business development and intellectual property (IP) officer.
- « Previous Page
- 1
- …
- 54
- 55
- 56
- 57
- 58
- …
- 201
- Next Page »




